Novartis Pharma AG v. Regeneron Pharmaceuticals, Inc.
| NOVARTIS PHARMA AG, NOVARTIS TECHNOLOGY LLC and NOVARTIS PHARMACEUTICALS CORPORATION |
| REGENERON PHARMACEUTICALS, INC. |
| 23-1334 |
| January 5, 2023 |
| U.S. Court of Appeals, Federal Circuit |
| Other |
Docket Report
RSS Track this Docket
This docket was last retrieved on January 5, 2023. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Filing 1 Appeal docketed. Received: 12/23/2022. [894837] Entry of Appearance due 01/19/2023. Certificate of Interest is due on 01/19/2023. Docketing Statement due 01/19/2023. Certified List due on 02/14/2023. [KMH] [Entered: 01/05/2023 11:54 AM] |
Access additional case information on PACER
Access the Case Summary and Docket Report to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
